close

Clinical Trials

1 2 3 205
Number of results: 4081

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-10-19 AMT-061 severe and moderately severe hemophilia B Uniqure (The Netherlands) Rare diseases - Genetic diseases - Hematological diseases
2017-10-18 BMN 111 (vosoritide) achondroplasia 2 Biomarin Pharmaceutical (USA - CA) Rare diseases - Genetic diseases
2017-10-18 PV-10 and pembrolizumab melanoma 1b-2 Provectus Pharmaceuticals (USA - TN) Cancer - Oncology
2017-10-18 BMN 270 (valoctocogene roxaparvovec) hemophilia A 3 Biomarin Pharmaceutical (USA - CA) Rare diseases - Genetic diseases - Hematological diseases
2017-10-18 BMN 270 hemophilia A 1-2 Biomarin Pharmaceutical (USA - CA) Rare diseases - Genetic diseases - Hematological diseases
2017-10-18 BMN 290 Friedreich's Ataxia Biomarin Pharmaceutical (USA - CA) Rare diseases - Neurodegenerative diseases
2017-10-18 AMT-130 (adeno-associated viral vector serotype 5 encoding a microRNA targeted to human huntingtin gene) Huntington's Disease preclinical Uniqure (The Netherlands) Rare diseases - Genetic diseases - Neurodegenerative diseases
2017-10-17 VXM10 preclinical Vaximm (Germany) Cancer - Oncology
2017-10-03 CYAD-01 - NKR-2 (NKG2D CAR T-Cell) colorectal cancer, ovarian Cancer, urothelial carcinoma, triple-negative breast cancer, pancreatic cancer, acute myeloid leukemia/myelodysplastic syndrome, multiple myeloma 1b Celyad (Belgium) Cancer - Oncology
2017-10-02 caplacizumab thrombotic thrombocytopenic purpura 3 Ablynx (Belgium) Autoimmune diseases - Rare diseases
2017-10-02 PRS-343 HER2-positive solid tumors 1 Pieris (Germany) Cancer - Oncology
2017-09-30 epacadostat and Keytruda® (pembrolizumab) advanced tumors 1-2 Incyte (USA - DE) Merck&Co (USA - NJ) Cancer - Oncology
2017-09-29 ZX008 (fenfluramine hydrochloride) Dravet syndrome 3 Zogenix (USA - NY) Rare diseases - Neurological diseases
2017-09-28 ABX464 HIV infection 1-2 Abivax (France) Infectious diseases
2017-09-28 AsiDNA™ and belinostat preclinical Onxeo (France) Cancer - Oncology
2017-09-28 pembrolizumab and olaptesed pegol (NOX-A12) metastatic colorectal cancer, metastatic pancreatic cancer 1-2 Noxxon Pharma (Germany) Merck&Co (USA - NJ) Cancer - Oncology
2017-09-27 Remygen® (gamma-Aminobutyric acid) Diamyd Medical (Sweden)
2017-09-27 RAD140 hormone receptor positive breast cancer 1 Radius Health (USA - MA) Cancer - Oncology
2017-09-22 Keyzilen™ (AM-101) acute peripheral tinnitus 3 Auris Medical (Switzerland) Otorhinolaryngology
2017-09-21 Tremfya® (guselkumab) psoriatic arthritis 3 Janssen Research & Development, a J&J company (USA - NJ) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases